Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients
Background: Cholangiocarcinoma (CCA) is a diverse group of aggressive liver tumors with up to 20% being intrahepatic CCA (iCCA). Up to 15% of patients with iCCA have fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements. Here we evaluated iCCA treatment with pemigatinib, a selective...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medical Journals Sweden
2025-04-01
|
| シリーズ: | Acta Oncologica |
| 主題: | |
| オンライン･アクセス: | https://medicaljournalssweden.se/actaoncologica/article/view/42073 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|